A comparison of diltiazem, esmolol, nifedipine and nitroprusside therapy of post-CABG hypertension.
Boylan
J F
JF
Department of Anaesthesia, Toronto General Hospital, University of Toronto, Ontario.
O'Leary
G
G
Weisel
R D
RD
Ivanov
J
J
Mickle
D A
DA
Teasdale
S J
SJ
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D001794:Blood Pressure / Q000187:drug effects; D001026:Coronary Artery Bypass; D003326:Coronary Circulation / Q000187:drug effects; D004110:Diltiazem / Q000008:administration & dosage*; D004734:Energy Metabolism / Q000187:drug effects; D005292:Ferricyanides / Q000008:administration & dosage*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007262:Infusions, Intravenous; D009206:Myocardium / Q000378:metabolism; D009543:Nifedipine / Q000008:administration & dosage*; D009599:Nitroprusside / Q000008:administration & dosage*; D011183:Postoperative Complications / Q000188:drug therapy*; D011412:Propanolamines / Q000008:administration & dosage*; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic
D000319:Adrenergic beta-Antagonists; D005292:Ferricyanides; D011412:Propanolamines; D009599:Nitroprusside; D004110:Diltiazem; D009543:Nifedipine; C036604:esmolol